期刊文献+

迷走神经切断协同改良胃旁路术治疗正常体重糖尿病研究应用 被引量:2

Combined application of pneumogastric nerves resection and modified gastric bypass procedures in treating diabetic patients with normal weight
原文传递
导出
摘要 目的探讨切断迷走神经胃支协同改良胃旁路(GBP)手术对正常体重2型糖尿病患者保持体重、消除胰岛素抵抗的临床效果。方法回顾分析22例体重正常的2型糖尿病,行高选迷走神经胃支切断(保留迷走神经的肝支、腹腔支和"罪恶神经"支)、改良胃旁路手术,观察术后1~3个月的体重指数(BMI)、胰岛素释放试验(Ins)、口服糖耐量试验(OGTT)、空腹血糖(FPG)、空腹胰岛素(Fins)、胰岛素抵抗指数(HOMO-IR)等指标与术前对照。结果 22例正常体重的2型糖尿病患者手术时间49~98min,平均66min。全组患者术后均恢复良好,无吻合口漏、出血、狭窄等手术并发症发生;无倾倒综合征、胃无力、腹泻、消化不良症等动力神经损伤的并发症发生。术后1个月患者Ins、OGTT、FPG、Fins、HOMO-IR等指标与术前比较,差异有统计学意义(P<0.05)。结论选择性迷走神经胃支协同改良胃旁路手术治疗正常体重的2型糖尿病,疗效确切。 Objective To investigate the results of combined treatment of pneumogastrie nerves resection and gastric bypass procedures (GBP) in treating patients with type 2 diabetes mellitus (DM) and normal weight. Methods Clinical data of 22 patients with type 2 DM and normal weight, who had undergone both selective pneumogastric nerves resection and GBP were analyzed retrospectively. Clinical observation included perioperative body mass index (BMI), insulin release testing (IRT), oral glucose tolerance test ( OGTI'), fasting plasma glucose (FPG) , fasting insulin ( Fins ) , insulin resistance index (HOMO-IR) etc. Results In 22 patients operation time ranged from 49 to 98 minutes (average 66 minutes). All the 22 patients recovered well after operation, without complications such as stoma leakage, bleeding, and stenosis. There was no occurrence of dumping syndromes, gastroplegia, diarrhea and dyspepsia, which were associated with pneumogastric nerves injury. Compared with pre-operation, there were significant differences in BMI, IRT, OGTI', FPG, Fins and HOMO-IR after operation (P 〈 0.05 ). Conclusions Combined treatment of pneumogastric nerves resection and gastric bypass procedures (GBP) is safe and effective for patients with type 2 DM and normal weight.
机构地区 解放军第
出处 《中华普外科手术学杂志(电子版)》 2012年第2期38-40,43,共4页 Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
关键词 迷走神经切断术 胃旁路术 糖尿病 2型 体重 Vegotomy Gastric bypass Diabetes meltitus, type2 Body weight
  • 相关文献

参考文献27

二级参考文献108

  • 1张新国,杨学军.手术治疗2型糖尿病的突破性进展[J].武警医学,2004,15(12):883-884. 被引量:61
  • 2张新国,杨学军,徐红,韩承新,贾元利,武金虎,张冶.胃旁路手术治疗Ⅱ型糖尿病的体会[J].中华普通外科杂志,2005,20(9):599-599. 被引量:100
  • 3张士虎,苗毅.胃旁路术对非肥胖型糖尿病大鼠的降糖作用[J].南京医科大学学报(自然科学版),2006,26(3):176-179. 被引量:13
  • 4张新国,杨学军,徐红,韩承新,贾元利,武金虎,张冶,高宏凯.胃转流手术治疗2型糖尿病胰岛素抵抗改变的临床研究[J].武警医学,2007,18(4):309-310. 被引量:36
  • 5Porios WJ, Swason MS, McDonald KG, et al. Who would have thought it?An operation proves to be the most effective therapy for adult-onset diabetes mellitus[J].Ann Surg,1995,222:339-350.
  • 6Mason EE.The mechanisms of surgical treatment of type 2 diabetes[J]. Obes Surg,2005,15:459-461.
  • 7Service GJ, Thompson GB, John Service F, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery[J].N Engl J Med,2005,353:249-254.
  • 8Naslund E, Kral JG.Impact of gastric bypass surgery on gut hormones and glucose homeostasis in type 2 diabect[J].Diabetes,2006,55(Suppl 2): s92-s97.
  • 9邹大进.深入2008EASD-手术治疗2型糖尿病[J].中国医学论坛报,2008,10:16C5.
  • 10Buteau J, El-Assaad W, Rhodes CJ, et al. Glucagon-like peptide-1 prevents beta cell glucolipotoxicity[J].Diabetes,2008,57:1205-1215.

共引文献232

同被引文献23

  • 1邓尚平,汪秀琼,周文璧,何德英,李双庆.单纯性肥胖者和糖尿病患者血清胰多肽水平观察[J].中华内分泌代谢杂志,1989,5(4):199-200. 被引量:3
  • 2Stearns AT,Balakrishnan A,Radmanesh A. Relative con- tributions of afferent vagal fibers to resistance to diet-in- duced obesity[J].Dig Dis Sci, 2012(57) : 1281-1290.
  • 3Simpson K,Parker J,Plumer J,et al. The control of energy balance[J]. Handb Exp Pharmacol, 2012 (209) : 209-230.
  • 4Schwartz TW. Pancreatic polypeptide:a unique model for vagal control of endocrine systems [J]. J Auton Nerv Syst,1983,9(1) :99-111.
  • 5Kreier F, Fliers E, Voshol PJ, et al. Selective parasympa- thetic innervation of subcutaneous and intra-abdominal fatfunctional implications[J]. J Clin Invest, 2002,110 (9) :1243-1250.
  • 6Ahren B. Autonomic regulation of islet hormone secre- tion:implications for health and disease[J].Diabetologia, 2000,43(4) :393-410.
  • 7Wierup N,Richards WG,Bannon AW, et al. CART knock Out mice have impaired insulin secretion and glucose intol- erance, altered beta cell morphology and increased bodywelght[J]. Regul Pept,2005,129(1/2/3) :203-211.
  • 8Glaser B, Zoghlin G,Pienta K, et al. Pancreatic polypep- tide response to secretin in obesity: effects of glucose in- tolerance[J]. Horm Metab Res,1988,20(5):288-292.
  • 9Glasbrenner B, Dominguez-Munoz E, Riepl RL, et al. Cho- lecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy[J]. Dig Dis Sei, 1995,40(2) :406-411.
  • 10Ramachandran A,Moses A,Shetty S,et al. A new non-in- vasive technology to screen for dysglycaemia including di- abetes[J]. Diabetes Res Clin Praet,2010(88) :302-306.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部